United States· US:70474-013_21efce2a-3107-4d37-e063-6394a90af7fb
Note Mattifying Extreme Wear Foundation 125 Ivory Beige
A octinoxate product containing octinoxate, registered in United States by ALTONA COSMETICS TECHNOLOGY SANAYI VE TICARET ANONIM SIRKETI. The same ATC class is registered in 2 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Octinoxate is registered in 2 of 19 countries.
Countries holding a registration under ATC D02BA02 (octinoxate), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 1 of them publish a price we can compare per daily dose
Octinoxate · ATC D02BA02
2 / 19 countries
- Canada
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OCTINOXATE
- Manufacturer
- ALTONA COSMETICS TECHNOLOGY SANAYI VE TICARET ANONIM SIRKETI
- Country
- United States (US)
- ATC code
- D02BA02
- ATC class
- Octinoxate
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1170474013011 BOTTLE in 1 CARTON (70474-013-01) / 30 mL in 1 BOTTLE
- ndc1170474-013-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Octinoxate in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/be76d634-031c-45d0-bb07-e2e0ddde05d6 GET /v1/drugs/be76d634-031c-45d0-bb07-e2e0ddde05d6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "6",
"substance": "OCTINOXATE",
"productndc": "70474-013",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "M020",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about octinoxate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.